Guangdong Hec Technology Holding Co Ltd
SSE:600673
Net Margin
Guangdong Hec Technology Holding Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Guangdong Hec Technology Holding Co Ltd
SSE:600673
|
28.5B CNY |
4%
|
|
| CN |
C
|
China Hongqiao Group Ltd
HKEX:1378
|
132.8B HKD |
14%
|
|
| IN |
|
Hindalco Industries Ltd
NSE:HINDALCO
|
1.4T INR |
6%
|
|
| CN |
|
Aluminum Corporation of China Ltd
SSE:601600
|
112.2B CNY |
6%
|
|
| CN |
A
|
Aluminum Corp of China Ltd
OTC:ALMMF
|
15.2B USD |
6%
|
|
| NO |
|
Norsk Hydro ASA
OSE:NHY
|
110.5B NOK |
5%
|
|
| MY |
|
Press Metal Aluminium Holdings Bhd
KLSE:PMETAL
|
41.5B MYR |
12%
|
|
| CN |
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
50.6B CNY |
7%
|
|
| US |
|
Alcoa Corp
NYSE:AA
|
6.9B USD |
7%
|
|
| RU |
|
OK Rusal MKPAO
MOEX:RUAL
|
470.5B RUB |
7%
|
|
| CN |
|
Shandong Nanshan Aluminium Co Ltd
SSE:600219
|
43.6B CNY |
16%
|
Guangdong Hec Technology Holding Co Ltd
Glance View
Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Guangdong Hec Technology Holding Co Ltd's most recent financial statements, the company has Net Margin of 4.4%.
You don't have any saved screeners yet